The EPIC Clinical Study: Effectiveness and Safety of Intermittent Antimicrobial Therapy for the Treatment of New Onset Pseudomonas Aeruginosa (Pa) Airway Infection in Young Patients with Cystic Fibrosis

Grants and Contracts Details

Description

NO ABSTRACT AVAILABLE
StatusFinished
Effective start/end date3/1/049/30/09

Funding

  • Cystic Fibrosis Foundation: $16,134.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.